![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 519/00 | (2006.01) |
A61K 31/433 | (2006.01) | ||
C07D 513/04 | (2006.01) | ||
A61K 31/5025 | (2006.01) | ||
C07D 487/04 | (2006.01) | ||
A61K 31/4355 | (2006.01) | ||
A61P 7/02 | (2006.01) |
(11) | Number of the document | 3243826 |
(13) | Kind of document | T |
(96) | European patent application number | 17172927.0 |
Date of filing the European patent application | 2013-04-24 | |
(97) | Date of publication of the European application | 2017-11-15 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
(46) | Date of publication of the claims translation | 2019-12-27 |
(30) | Number | Date | Country code |
201261638577 P | 2012-04-26 | US | |
201361787680 P | 2013-03-15 | US |
(72) |
BANVILLE, Jacques, CA
RÉMILLARD, Roger, CA
RUEDIGER, Edward H., CA
DEON, Daniel H., US
GAGNON, Marc, CA
DUBÉ, Laurence, CA
GUY, Julia, CA
PRIESTLEY, Eldon Scott, US
POSY, Shoshana L., US
MAXWELL, Brad D., US
WONG, Pancras C., US
LAWRENCE, Michael R., US
MILLER, Michael M., US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
Université de Montréal, 2900 Boulevard Édouard-Montpetit, Montréal QC H3T 1J4, CA |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Imidazotiadiazolo ir imidazopirazino dariniai kaip proteazę aktyvinančio receptoriaus 4 (PAR4) inhibitoriai, skirti gydyti trombocitų agregaciją |
IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION |
Payment date | Validity (years) | Amount | |
2025-05-19 | 13 | 433.50 EUR |
2026-04-24 |